Dexcom Inc. buy Royal Bank of Canada
Start price
12.03.24
/
50%
€123.00
Target price
12.03.25
€151.16
Performance (%)
-47.28%
End price
13.03.25
€64.85
Summary
This prediction ended on 13.03.25 with a price of €64.85. Massive losses of -47.28% were the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has a follow-up prediction for Dexcom Inc. where he still thinks Dexcom Inc. is a Buy. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Dexcom Inc. | -6.165% | -6.165% | -13.924% |
| iShares Core DAX® | 0,75 % | -8,50 % | 2,57 % |
| iShares Nasdaq 100 | -1,41 % | -2,77 % | 15,68 % |
| iShares Nikkei 225® | 0,42 % | -9,29 % | 29,65 % |
| iShares S&P 500 | -0,59 % | -2,87 % | 9,96 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Dexcom Inc. diskutieren
DexCom, Inc. (NASDAQ: DXCM) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $165.00 price target on the stock.
Ratings data for DXCM provided by MarketBeat
In the thread Trading Dexcom Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten

